Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Reloading in Resistant ACS
NCT00444132Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clopidogrel in acute coronary syndrome (ACS), sponsored by Sheba Medical Center. Primary endpoint: Platelet reactivity. Started Mar 2005; status: completed.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00444132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444132.